Skip to content
OpenCapital
Get started

InnovAge Holdings, Inc. INNV Indefinite- lived intangible impairment

Indefinite- lived intangible impairment at other companies

Humana logo
HumanaHUM
——

Other financials

Income statement

See full
Revenue$251.9M+15.5%
Operating income-$29.1M-186%
Net income-$29.5M-159%
EPS (diluted)-$0.22-175%

Balance sheet

See full
Cash & equivalents$95.5M+58.0%
Total debt$93.8M-11.0%
Total equity$229.0M-3.8%
Total assets$547.4M+2.0%

Cash flow

See full
Operating cash flow$18.1M-26.3%
CapEx$3.6M+24.3%
Free cash flow$14.5M-33.1%

Valuation

See full
Market cap$1.31B+150%
Enterprise value$1.31B+130%
P/S1.4×+0.7×

Profitability

See full
Operating margin-1%-0.4pp
Net margin-1.2%-0.5pp
FCF margin4.5%+2.6pp

Returns & leverage

See full
Return on equity-5%-1.8pp
Debt / equity0.4×0.0×
Current ratio1×+0.3×

Where this comes from

Reported directly by InnovAge Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IntangibleAssetsGrossExcludingGoodwill.

The official record: InnovAge Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about InnovAge Holdings, Inc.'s indefinite- lived intangible impairment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is InnovAge Holdings, Inc.'s indefinite- lived intangible impairment?
InnovAge Holdings, Inc. (INNV) reported indefinite- lived intangible impairment of $8.6M in Q1 2026.
How has InnovAge Holdings, Inc.'s indefinite- lived intangible impairment changed year-over-year?
InnovAge Holdings, Inc.'s indefinite- lived intangible impairment decreased by 0.0% year-over-year, from $8.6M to $8.6M.
What is the long-term trend for InnovAge Holdings, Inc.'s indefinite- lived intangible impairment?
Over 3 years (2022 to 2025), InnovAge Holdings, Inc.'s indefinite- lived intangible impairment has grown at a 0.0% compound annual growth rate (CAGR), from $8.6M to $8.6M.